Metadata
- Name
- A Safety Study of Human Cord Blood Derived, Culture Expanded Natural Killer Cell (PNK-007) Infusion With Subcutaneous Recombinant Human IL-2 (rhIL-2) in Adults With Relapsed and/or Refractory Acute Myeloid Leukemia (AML)
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT02781467
- Description
- This study will find the highest acceptable treatment dose of cord blood, culture expanded
natural killer (NK) cells, a kind of immune cell, in patients with relapsed and/or refractory
acute myeloid leukemia.
The NK cells will be given with chemotherapy and Recombinant human interleukin 2 (rhIL-2) to
help the NK cells expand in the body. The safety of this treatment will be studied and
researchers want to learn if NK cells will help in treating the AML. - Data or Study Types
- clinical trial
- Keywords
- Fludarabine, Leukemia, Acute Myeloid, RHIL-2, Human IL-2, PNK-007, Cyclophosphamide
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2016
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT02781467
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT02781467